TechieindusTrader

Glenmark Long Term Analysis

Long
NSE:GLENMARK   GLENMARK PHARM
1. At crucial support Zone
2. Current price less than intrinsic value
3. Volumetric profile average is 485 and trading near that level
4. Dividend yield of 5%

Comment:
1. It was suggested at 483 , gave move upto 528 .
2. Now its at confluence of 200 and 100 EMA , Pharma is moving in Improvin quadrant in RRG , stay invested , next target 550

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.